Bankruptcy Court gave an order approving the sale of the certain assets of Generex Biotechnology Corporation on January 19, 2024. The debtor has been authorized to sell its certain assets to Beijing Youfeng Biological Technology Co., Ltd., for a purchase price of $0.01 million in cash, waive or withdraw the proof of claim in the amount of $55.1 million, and assign to Debtor all claims it has against Mazars, with good-faith deposit in the amount of $0.01 million. The debtor?s assets include equity of various subsidiaries and any remaining intellectual property owned by Generex Biotechnology Corp.